↓ Skip to main content

Cochrane Database of Systematic Reviews

Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews

Overview of attention for article published in Cochrane database of systematic reviews, February 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
1 news outlet
twitter
63 tweeters
facebook
1 Facebook page
googleplus
1 Google+ user

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
123 Mendeley
Title
Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews
Published in
Cochrane database of systematic reviews, February 2014
DOI 10.1002/14651858.cd010314.pub2
Pubmed ID
Authors

Christopher J Cates, L. Susan Wieland, Marta Oleszczuk, Kayleigh M Kew

Abstract

For adults with asthma that is poorly controlled on inhaled corticosteroids (ICS), guidelines suggest adding a long-acting beta2-agonist (LABA). The LABA can be taken together with ICS in a single (combination) inhaler. Improved symptom control can be assessed in the individual; however, the long-term risk of hospital admission or death requires evidence from randomised controlled trials. Clinical trials record these safety outcomes as non-fatal and fatal serious adverse events (SAEs), respectively.

Twitter Demographics

The data shown below were collected from the profiles of 63 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 123 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 123 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 20 16%
Student > Ph. D. Student 12 10%
Student > Bachelor 9 7%
Student > Doctoral Student 7 6%
Researcher 6 5%
Other 20 16%
Unknown 49 40%
Readers by discipline Count As %
Medicine and Dentistry 28 23%
Nursing and Health Professions 19 15%
Psychology 5 4%
Social Sciences 5 4%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Other 9 7%
Unknown 52 42%

Attention Score in Context

This research output has an Altmetric Attention Score of 46. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 July 2018.
All research outputs
#630,006
of 19,446,267 outputs
Outputs from Cochrane database of systematic reviews
#1,450
of 11,933 outputs
Outputs of similar age
#8,342
of 273,114 outputs
Outputs of similar age from Cochrane database of systematic reviews
#29
of 179 outputs
Altmetric has tracked 19,446,267 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,933 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 27.5. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 273,114 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 179 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.